3,054 Shares in McKesson Co. (NYSE:MCK) Purchased by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. bought a new stake in shares of McKesson Co. (NYSE:MCK - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,054 shares of the company's stock, valued at approximately $1,414,000.

Other institutional investors have also recently made changes to their positions in the company. Raymond James & Associates increased its stake in shares of McKesson by 6.1% in the 4th quarter. Raymond James & Associates now owns 153,180 shares of the company's stock worth $70,919,000 after purchasing an additional 8,784 shares in the last quarter. Insight Wealth Strategies LLC purchased a new position in McKesson during the fourth quarter worth approximately $1,813,000. Aspire Private Capital LLC boosted its position in shares of McKesson by 3.2% during the third quarter. Aspire Private Capital LLC now owns 1,957 shares of the company's stock worth $851,000 after buying an additional 60 shares during the period. Argus Investors Counsel Inc. acquired a new position in shares of McKesson during the fourth quarter worth $891,000. Finally, Nordea Investment Management AB boosted its holdings in shares of McKesson by 5.7% in the fourth quarter. Nordea Investment Management AB now owns 756,560 shares of the company's stock valued at $350,734,000 after acquiring an additional 40,907 shares during the period. Hedge funds and other institutional investors own 85.07% of the company's stock.

McKesson Price Performance

Shares of NYSE MCK traded down $0.36 during midday trading on Friday, reaching $523.01. 484,479 shares of the company traded hands, compared to its average volume of 499,445. The company has a market cap of $68.73 billion, a price-to-earnings ratio of 23.70, a PEG ratio of 1.42 and a beta of 0.45. McKesson Co. has a 52 week low of $352.34 and a 52 week high of $543.00. The stock has a 50-day moving average price of $523.05 and a 200 day moving average price of $483.69.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Wednesday, February 7th. The company reported $7.74 earnings per share for the quarter, beating the consensus estimate of $7.05 by $0.69. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The company had revenue of $80.90 billion for the quarter, compared to analyst estimates of $77.93 billion. During the same period in the prior year, the company posted $6.90 EPS. The company's revenue was up 14.8% compared to the same quarter last year. As a group, analysts expect that McKesson Co. will post 27.59 EPS for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, April 1st. Shareholders of record on Friday, March 1st were paid a $0.62 dividend. This represents a $2.48 annualized dividend and a yield of 0.47%. The ex-dividend date was Thursday, February 29th. McKesson's dividend payout ratio (DPR) is currently 11.24%.

Insider Transactions at McKesson

In other McKesson news, EVP Leann B. Smith sold 186 shares of the company's stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the sale, the executive vice president now owns 1,511 shares in the company, valued at $749,456. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CEO Brian S. Tyler sold 3,473 shares of the company's stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $524.55, for a total value of $1,821,762.15. Following the completion of the sale, the chief executive officer now owns 43,445 shares of the company's stock, valued at $22,789,074.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Leann B. Smith sold 186 shares of the firm's stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total transaction of $92,256.00. Following the transaction, the executive vice president now owns 1,511 shares of the company's stock, valued at approximately $749,456. The disclosure for this sale can be found here. 0.21% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Leerink Partnrs reiterated an "outperform" rating on shares of McKesson in a research note on Monday, February 26th. Barclays assumed coverage on shares of McKesson in a report on Wednesday, January 3rd. They set an "overweight" rating and a $537.00 price target on the stock. UBS Group lifted their target price on shares of McKesson from $575.00 to $620.00 and gave the company a "buy" rating in a research report on Wednesday, March 6th. SVB Leerink began coverage on McKesson in a report on Monday, February 26th. They issued an "outperform" rating and a $600.00 price objective for the company. Finally, Mizuho increased their price objective on shares of McKesson from $450.00 to $505.00 and gave the stock a "neutral" rating in a research note on Friday, February 9th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat.com, McKesson currently has a consensus rating of "Moderate Buy" and an average target price of $528.64.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.